| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.096 | 0.06 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |